204242

Sigma-Aldrich

Bis(triphenylphosphine)rhodium(I) carbonyl chloride

99.9%

Synonym(s):
RhCl(CO)(PPh3)2, Rhodiumbis(triphenylphosphine) carbonyl chloride, Chlorocarbonylbis(triphenylphosphine)rhodium(I)
Linear Formula:
[(C6H5)3P]2RhCl(CO)
CAS Number:
Molecular Weight:
690.94
Beilstein/REAXYS Number:
4618896
EC Number:
MDL number:
PubChem Substance ID:
NACRES:
NA.22
Pricing and availability is not currently available.

Quality Level

assay

99.9%

reaction suitability

core: rhodium
reagent type: catalyst

mp

224-227 °C (dec.) (lit.)

SMILES string

Cl[Rh].[C-]#[O+].c1ccc(cc1)P(c2ccccc2)c3ccccc3.c4ccc(cc4)P(c5ccccc5)c6ccccc6

InChI

1S/2C18H15P.CO.ClH.Rh/c2*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-2;;/h2*1-15H;;1H;/q;;;;+1/p-1

InChI key

SGULOPRLUCGLSH-UHFFFAOYSA-M

Looking for similar products? Visit Product Comparison Guide

Packaging

1 g in glass bottle

Application

Used for cyclometallation.

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

RIDADR

NONH for all modes of transport

WGK Germany

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Jiang, X.; Shengming, M. J.
Journal of the American Chemical Society, 129 (2007)
Xuefeng Jiang et al.
Journal of the American Chemical Society, 129(37), 11600-11607 (2007-08-30)
Cyclometallation of two unsaturated carbon-carbon bonds usually requires the application of low-valent metal catalysts, which could cleave the propargylic ester linkage. Thus, it is desirable to identify a catalyst which could undergo cyclometallation without cleaving the propargylic ester linkage. In...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.